BackTarsus Pharmaceuticals Overview

Tarsus Pharmaceuticals Net Income

Profitability analysis for TARS.

Quarterly Net Income

-$6.97M
72.27% YoY

As of Mar 2026

Annual Net Income (TTM)

-$48.27M
54.01% YoY

Trailing 12 months ending Mar 2026

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...